Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1

Nature Immunology

Volumn 17, Issue 9, 2016, Pages 1067-1074

  Garcia Beltran, Wilfredo F ^a   Hölzemer, Angelique ^a,c   Martrus, Gloria ^b   Chung, Amy W ^a   Pacheco, Yovana ^a,d   Simoneau, Camille R ^a   Rucevic, Marijana ^a   Lamothe Molina, Pedro A ^a   Pertel, Thomas ^e   Kim, Tae Eun ^a   Dugan, Haley ^a   Alter, Galit ^a   Dechanet Merville, Julie ^f   Jost, Stephanie ^a   Carrington, Mary ^a,g   Altfeld, Marcus ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Universidad Nuestra Seora del Rosario   (Colombia)

^e HARVARD MEDICAL SCHOOL   (United States)

^f CNRS Bordeaux Segalen University   (France)

^g FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA F ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; MESSENGER RNA; CYTOKINE; HLA ANTIGEN CLASS 1; HLA-F ANTIGENS; LIGAND;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HEAVY CHAIN; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; LIGAND BINDING; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR AFFINITY; SURFACE PLASMON RESONANCE; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION; AGONISTS; CYTOTOXICITY; DISEASE COURSE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; IMMUNOLOGY; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; PRIMARY CELL CULTURE; VIRUS LATENCY;

CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; JURKAT CELLS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE ACTIVATION; PRIMARY CELL CULTURE; RECEPTORS, KIR3DS1; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84980357055     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3513     Document Type: Article

References (55)

1. Parham, P., Norman, P.J., Abi-Rached, L., & Guethlein, L.A. Variable NK cell receptors exemplified by human KIR3DL1/S1. J. Immunol. 187, 11-19 (2011
2. Vivier, E., & Ugolini, S. Natural killer cells: from basic research to treatments. Front. Immunol. 2, 18 (2011
3. Rajalingam, R. Human diversity of killer cell immunoglobulin-like receptors and disease. Korean J. Hematol. 46, 216-228 (2011
4. Min-Oo, G., Kamimura, Y., Hendricks, D.W., Nabekura, T., & Lanier, L.L. Natural killer cells: walking three paths down memory lane. Trends Immunol. 34, 251-258 (2013
5. Waggoner, S.N., Cornberg, M., Selin, L.K., & Welsh, R.M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481, 394-398 (2011
6. Martin, M.P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31, 429-434 (2002
7. Jiang, Y. et al. KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-Term nonprogressors. BMC Infect. Dis. 13, 405 (2013
8. Rivero-Juarez, A. et al. Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patients. PLoS One 8, e61992 (2013
9. Trydzenskaya, H. et al. The genetic predisposition of natural killer cell to BK virus-Associated nephropathy in renal transplant patients. Kidney Int. 84, 359-365 (2013
10. Díaz-Peña, R. et al. Association of the KIR3DS1.∗013 and KIR3DL1.∗004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum. 62, 1000-1006 (2010
11. López-Vázquez, A. et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J. Infect. Dis. 192, 162-165 (2005
12. Besson, C. et al. Association of killer cell immunoglobulin-like receptor genes with Hodgkin?s lymphoma in a familial study. PLoS One 2, e406 (2007
13. Carrington, M. et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J. Exp. Med. 201, 1069-1075 (2005
14. Gagne, K. et al. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 15, 1366-1375 (2009
15. Venstrom, J.M. et al. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood 115, 3162-3165 (2010
16. Carr, W.H. et al. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-Associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178, 647-651 (2007
17. Cella, M., Longo, A., Ferrara, G.B., Strominger, J.L., & Colonna, M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180, 1235-1242 (1994
18. O'Connor, G.M. et al. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 178, 235-241 (2007
19. Gillespie, G.M. et al. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res. Hum. Retroviruses 23, 451-455 (2007
20. O'Connor, G.M. et al. Peptide-dependent recognition of HLA-B.∗57: 01 by KIR3DS1. J. Virol. 89, 5213-5221 (2015
21. Martin, M.P. et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39, 733-740 (2007
22. Barbour, J.D. et al. Synergy or independence?. Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 3, e43 (2007
23. Long, B.R. et al. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J. Virol. 82, 4785-4792 (2008
24. Gardiner, C.M. et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J. Immunol. 166, 2992-3001 (2001
25. Thananchai, H. et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178, 33-37 (2007
26. Sharma, D. et al. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A 2402. J. Immunol. 183, 4569-4582 (2009
27. Arosa, F.A., Santos, S.G., & Powis, S.J. Open conformers: the hidden face of MHC-I molecules. Trends Immunol. 28, 115-123 (2007
28. Wainwright, S.D., Biro, P.A., & Holmes, C.H. HLA-F is a predominantly empty, intracellular, TAP-Associated MHC class Ib protein with a restricted expression pattern. J. Immunol. 164, 319-328 (2000
29. Goodridge, J.P., Burian, A., Lee, N., & Geraghty, D.E. HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J. Immunol. 184, 6199-6208 (2010
30. Trundley, A., Frebel, H., Jones, D., Chang, C., & Trowsdale, J. Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur. J. Immunol. 37, 780-787 (2007
31. Lee, N., Ishitani, A., & Geraghty, D.E. HLA-F is a surface marker on activated lymphocytes. Eur. J. Immunol. 40, 2308-2318 (2010
32. Alter, G. et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204, 3027-3036 (2007
33. Allen, R.L., Raine, T., Haude, A., Trowsdale, J., & Wilson, M.J. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J. Immunol. 167, 5543-5547 (2001
34. Jones, D.C. et al. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J. Immunol. 186, 2990-2997 (2011
35. Lepin, E.J.M. et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur. J. Immunol. 30, 3552-3561 (2000
36. Goodridge, J.P., Burian, A., Lee, N., & Geraghty, D.E. HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors. J. Immunol. 191, 3553-3562 (2013
37. Vivian, J.P et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479, 401-405 (2011
38. Pan, F.H., Liu, X.X., & Tian, W. Characterization of HLA-F polymorphism in four distinct populations in Mainland China. Int. J. Immunogenet. 40, 369-376 (2013
39. Shiina, T. et al. Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1, 796, 938-bp HLA class I region. Proc. Natl. Acad. Sci. USA 96, 13282-13287 (1999
40. Lee, N., & Geraghty, D.E. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J. Immunol. 171, 5264-5271 (2003
41. Noguchi, K. et al. Detection of anti-HLA-F antibodies in sera from cancer patients. Anticancer Res. 24 5C, 3387-3392 (2004
42. Le Gall, S. et al. Nef interacts with the ? subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495 (1998
43. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401 (1998
44. Cohen, G.B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671 (1999
45. Cerboni, C. et al. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 88, 242-250 (2007
46. Derrien, M. et al. Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. J. Gen. Virol. 85, 1945-1954 (2004
47. Boyle, L.H., Gillingham, A.K., Munro, S., & Trowsdale, J. Selective export of HLA-F by its cytoplasmic tail. J. Immunol. 176, 6464-6472 (2006
48. Jinushi, M., Hodi, F.S., & Dranoff, G. Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity. Proc. Natl. Acad. Sci. USA 103, 9190-9195 (2006
49. Jinushi, M. et al. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc. Natl. Acad. Sci. USA 105, 1285-1290 (2008
50. Pelak, K. et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol. 9, e1001208 (2011
51. Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365 (2011
52. Sanjana, N.E., Shalem, O., & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783-784 (2014
53. Mandal, P.K. et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15, 643-652 (2014
54. Cella, M., & Colonna, M. in Methods in Molecular Biology: Natural Killer Cell Protocols: Cellular and Molecular Methods Vol. 121 (eds. Campbell, K. S., & Colonna, M.) 1-4 (Humana Press, 1999
55. Imai, C., Iwamoto, S., & Campana, D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 106, 376-383 (2005